TSE:OPS

Opsens Competitors

C$1.98

+0.06 (+3.13 %)

(As of 05/14/2021 12:00 AM ET)

Add

Compare

Today's Range

C$1.86

▼

C$2.06

50-Day Range

C$1.62

▼

C$2.25

52-Week Range

C$0.59

▼

C$2.36

Volume102,424 shs

Average Volume216,996 shs

Market CapitalizationC$211.15 million

P/E Ratio141.43

Dividend YieldN/A

BetaN/A

Opsens (TSE:OPS) Vs. PHO, GPS, PNG, XCT, NSCI, and MDX

Should you be buying OPS stock or one of its competitors? Companies in the industry of "scientific & technical instruments" are considered alternatives and competitors to Opsens, including Photon Control (PHO), BSM Technologies (GPS), Kraken Robotics (PNG), exactEarth (XCT), Nanalysis Scientific (NSCI), and MedX Health (MDX).

Opsens vs. Photon Control Stock

Photon Control (TSE:PHO) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Photon Control and Opsens, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Photon Control	0	0	2	0	3.00
Opsens	0	0	3	0	3.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Opsens' higher probable upside, analysts plainly believe Opsens is more favorable than Photon Control.

Profitability

This table compares Photon Control and Opsens' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Photon Control	N/A	N/A	N/A
Opsens	N/A	N/A	N/A

Earnings and Valuation

This table compares Photon Control and Opsens' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Photon Control	C$64.66 million	5.84	C$13.60 million	C$0.13	27.77
Opsens	C$31.37 million	6.73	C$1.49 million	C$0.01	141.43

Photon Control has higher revenue and earnings than Opsens. Photon Control is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats Photon Control on 4 of the 7 factors compared between the two stocks.

Opsens vs. BSM Technologies Stock

BSM Technologies (TSE:GPS) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for BSM Technologies and Opsens, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BSM Technologies	0	0	0	0	N/A
Opsens	0	0	3	0	3.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%.

Profitability

This table compares BSM Technologies and Opsens' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BSM Technologies	N/A	N/A	N/A
Opsens	N/A	N/A	N/A

Earnings and Valuation

This table compares BSM Technologies and Opsens' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BSM Technologies	C$59.95 million	0.00	C$-20,699,037.00	C($0.26)	N/A
Opsens	C$31.37 million	6.73	C$1.49 million	C$0.01	141.43

Opsens has lower revenue, but higher earnings than BSM Technologies. BSM Technologies is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats BSM Technologies on 4 of the 5 factors compared between the two stocks.

Opsens vs. Kraken Robotics Stock

Kraken Robotics (CVE:PNG) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of current recommendations for Kraken Robotics and Opsens, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kraken Robotics	0	0	1	0	3.00
Opsens	0	0	3	0	3.00

Kraken Robotics presently has a consensus target price of C$1.00, indicating a potential upside of 72.41%. Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Kraken Robotics' higher probable upside, equities research analysts plainly believe Kraken Robotics is more favorable than Opsens.

Profitability

This table compares Kraken Robotics and Opsens' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kraken Robotics	N/A	N/A	N/A
Opsens	N/A	N/A	N/A

Earnings & Valuation

This table compares Kraken Robotics and Opsens' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kraken Robotics	C$12.27 million	7.93	C$-6,041,592.00	C($0.04)	-16.11
Opsens	C$31.37 million	6.73	C$1.49 million	C$0.01	141.43

Opsens has higher revenue and earnings than Kraken Robotics. Kraken Robotics is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats Kraken Robotics on 5 of the 7 factors compared between the two stocks.

Opsens vs. exactEarth Stock

exactEarth (TSE:XCT) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of current recommendations for exactEarth and Opsens, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
exactEarth	0	0	0	0	N/A
Opsens	0	0	3	0	3.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Opsens' higher probable upside, analysts plainly believe Opsens is more favorable than exactEarth.

Profitability

This table compares exactEarth and Opsens' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
exactEarth	N/A	N/A	N/A
Opsens	N/A	N/A	N/A

Earnings & Valuation

This table compares exactEarth and Opsens' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
exactEarth	C$20.37 million	3.03	C$-13,095,770.00	C($0.27)	-4.72
Opsens	C$31.37 million	6.73	C$1.49 million	C$0.01	141.43

Opsens has higher revenue and earnings than exactEarth. exactEarth is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats exactEarth on 7 of the 7 factors compared between the two stocks.

Opsens vs. Nanalysis Scientific Stock

Nanalysis Scientific (CVE:NSCI) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Earnings & Valuation

This table compares Nanalysis Scientific and Opsens' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanalysis Scientific	C$7.87 million	3.86	C$-3,962,220.00	C($0.06)	-7.67
Opsens	C$31.37 million	6.73	C$1.49 million	C$0.01	141.43

Opsens has higher revenue and earnings than Nanalysis Scientific. Nanalysis Scientific is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Nanalysis Scientific and Opsens' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanalysis Scientific	N/A	N/A	N/A
Opsens	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Nanalysis Scientific and Opsens, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanalysis Scientific	0	0	0	0	N/A
Opsens	0	0	3	0	3.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Opsens' higher probable upside, analysts plainly believe Opsens is more favorable than Nanalysis Scientific.

Summary

Opsens beats Nanalysis Scientific on 7 of the 7 factors compared between the two stocks.

Opsens vs. MedX Health Stock

MedX Health (CVE:MDX) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.

Valuation & Earnings

This table compares MedX Health and Opsens' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MedX Health	C$530,066.00	49.78	C$-3,342,575.00	C($0.02)	-7.89
Opsens	C$31.37 million	6.73	C$1.49 million	C$0.01	141.43

Opsens has higher revenue and earnings than MedX Health. MedX Health is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares MedX Health and Opsens' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MedX Health	N/A	N/A	N/A
Opsens	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings for MedX Health and Opsens, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MedX Health	0	0	0	0	N/A
Opsens	0	0	3	0	3.00

Opsens has a consensus target price of C$3.13, suggesting a potential upside of 57.83%. Given Opsens' higher probable upside, analysts clearly believe Opsens is more favorable than MedX Health.

Summary

Opsens beats MedX Health on 6 of the 7 factors compared between the two stocks.